Up-regulation of cell cycle-associated genes by p53 in apoptosis of an erythroleukemic cell line

Leukemia

Volumn 11, Issue SUPPL. 3, 1997, Pages 389-392

  Kato, Mitsuo V ^a   Sato, Hiromi ^a   Anzai, Hiroko ^a   Nagayoshi, Mariko ^a   Ikawa, Yoji ^a,b  

^a RIKEN TSUKUBA INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLIN G; CYCLINE; DNA FRAGMENT; FAS ANTIGEN; MUTANT PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; CANCER CELL CULTURE; CELL CYCLE; CELL NUCLEUS; CODON; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOPLASM; DNA REPLICATION; ERYTHROLEUKEMIA CELL; ETIOLOGY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GROWTH RATE; INTRACELLULAR TRANSPORT; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TEMPERATURE SENSITIVITY; TRANSACTIVATION;

EID: 0030763046     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Greenblatt, M.S. et al. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
2. Eliyahu, D. et al. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene, 3: 313-321, 1988.
3. Finlay, C.A. et al. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8: 531-539, 1988.
4. Chen, P.L. et al. Genetic mechanisms of tumor suppression by the human p53 gene. Science (Wash. DC), 250: 1576-1580, 1990.
5. Eliyahu, D. et al. Wild-type p53 can inhibit oncogene-mediated focus formation. Proc. Natl. Acad. Sci. USA, 86: 8763-8767, 1989.
6. Finlay, C.A. et al. The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57: 1083-1093, 1989.
7. Yonish-Rouach, E. et al. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.